期刊
IMMUNITY
卷 36, 期 6, 页码 947-958出版社
CELL PRESS
DOI: 10.1016/j.immuni.2012.04.008
关键词
-
类别
资金
- National Institutes of Health [AI057481, AI074944, AI073947]
- Center for Neuroscience and Regenerative Medicine (CNRM)
- American Heart Association
The adaptor protein BcI10 is a critically important mediator of T cell receptor (TCR)-to-NF-kappa B signaling. BcI10 degradation is a poorly understood biological phenomenon suggested to reduce TCR activation of NF-kappa B. Here we have shown that TCR engagement triggers the degradation of BcI10 in primary effector T cells but not in naive T cells. TCR engagement promoted K63 polyubiquitination of BcI10, causing BcI10 association with the autophagy adaptor p62. Paradoxically, p62 binding was required for both BcI10 signaling to NF-kappa B and gradual degradation of BcI10 by autophagy. BcI10 autophagy was highly selective, as shown by the fact that it spared Malt1, a direct BcI10 binding partner. Blockade of BcI10 autophagy enhanced TCR activation of NF-kappa B. Together, these data demonstrate that selective autophagy of BcI10 is a pathway-intrinsic homeostatic mechanism that modulates TCR signaling to NF-kappa B in effector I cells. This homeostatic process may protect T cells from adverse consequences of unrestrained NF-kappa B activation, such as cellular senescence.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据